Showing results (21-30 of 409) with videos related to

Sort By:
Pageof 41
Molecular Therapy. Oncology|May 22, 2026
Distinct bile mycobiome signature identifies fungal peptide panel predictive for gallbladder carcinomaSanju Yadav, Nupur Sharma, Manisha Yadav, et al.
Molecular Therapy. Oncology|June 8, 2026
CpG 1018 augments mRNA vaccine-induced anti-tumor immunity by potentiating CD8+ T cell responsesYibo Li, Jayachandra Reddy Nakkala, Labone Akter, et al.
Molecular Therapy. Oncology|April 30, 2026
LMTK3 as a spatially regulated and stage-dependent biomarker in epithelial ovarian tumorigenesisElla Ittner, Lucas Werner, Hugo Swenson, et al.
Molecular Therapy. Oncology|May 11, 2026
CAR-T cells directed toward PD-L1 demonstrate potent, antigen-specific activity against cholangiocarcinoma: A proof of concept studyPiyush Gondaliya, Yan Luo, Adil Ali Sayyed, et al.
Molecular Therapy. Oncology|May 7, 2026
Enable CAR T cell immunotherapy in glioblastoma by modifying its microenvironment via oncolytic adenovirus encoding bispecific T cell engagerMoon Jung Choi, Eui Young So, Bedia Akosman, et al.
Molecular Therapy. Oncology|May 6, 2026
Non-viral targeted integration at the CISH locus enables CAR-NK cell engineering with enhanced anti-tumor activityJiao Wang, Yao Sun, Jakob Starzyk, et al.
Molecular Therapy. Oncology|April 17, 2026
Mesothelin biology and the evolving landscape of targeted immunotherapyRemy Boisgard, Patrick Chames, Brigitte Kerfelec
Molecular Therapy. Oncology|March 11, 2026
Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cellsJeong-Hoon Jeong, Yu Ri Seo, Seung Rok Yu, et al.
Molecular Therapy. Oncology|February 20, 2026
Potency-enhancing mutations in E3-19K and i-leader increase the cytolytic activity of the PH20/SPAM1-armed oncolytic adenovirus Ad5Δ24RGDAleksei A Stepanenko, Anastasiia O Sosnovtseva, Anastasiia A Vasiukova, et al.
Molecular Therapy. Oncology|February 9, 2026
The emerging role of aptamers in targeted cancer immunotherapySai Zhu, Ruiling Xu, Haodong Xu, et al.
Pageof 41